Spok Holdings, Inc.

NASDAQ:SPOK

Medical - Healthcare Information Services

Healthcare
$10.93 +1.60%

+$0.17 today

Market cap
$228.30M
Beta
0.44
P/E (TTM)
17.2
EPS (TTM)
$0.61
Dividend yield
11.93%
52W Low $9.95High $19.31

Volume 0.18M

Average 0.17M

SPOK Operating Cash Flow

Cash generated by the company's core business operations during the period.

Spok Holdings, Inc.NASDAQ: SPOK

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow growth accelerates

Q1 FY2026 operating cash flow of $2.44M rose 8.4% year over year, ahead of the -0.1% change in trailing-twelve-month operating cash flow. Sequentially, it fell 78.8% from the prior quarter. Over 3 fiscal years it compounded at +64.9% a year.

Context

  • Operating cash flow amounted to 20.7% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Operating cash flow increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +8.4% holds above the trailing-twelve-month pace of -0.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.44M-78.8% QoQ
Last fiscal yearDec 2025
$28.95M+0.1% YoY
LTMMar 2026
$29.14M-0.1% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.4%——
1 year+0.1%——
3-year CAGR+64.9%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
28.95M USD
Year-over-year change
+0.1%
4-year CAGR
+38.1%

Operating Cash Flow vs competitors

How SPOK compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -0.1% is the 6th highest of 11, against a peer median of +0.3%.
  • Operating cash flow amounts to 21.3% of revenue for SPOK, versus a peer median of 19.7%.
SPOK Competitors
Operating Cash Flow for SPOK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SENSSenseonics Holdings, Inc.LTM Mar 2026$75.07M USD+33.4%-3.7%184.4%
CGCCanopy Growth CorporationLTM Mar 2026CA$70.22M CAD-57.6%-45.8%22.5%
VMDViemed Healthcare, Inc.LTM Mar 2026$57.13M USD+40.1%+23.2%19.9%
TBRGTruBridge, Inc.LTM Mar 2026$46.66M USD+16.9%+4.5%13.5%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$42.12M USD+8.2%-18.5%51.9%
DHDefinitive Healthcare Corp.LTM Mar 2026$39.28M USD-42.0%+14.8%16.5%
SPOKSpok Holdings, Inc.LTM Mar 2026$29.14M USD-0.1%+64.9%21.3%
NRCNational Research CorporationLTM Mar 2026$26.98M USD-7.7%-10.0%19.5%
SLPSimulations Plus, Inc.LTM Feb 2026$24.38M USD+107.6%+0.4%30.3%
MASS908 Devices Inc.LTM Mar 2026$7.59M USD-78.9%+4.2%13.1%
CERSCerus CorporationLTM Mar 2026$2.63M USD-69.2%—1.2%
Peer median (excluding SPOK) —+0.3%+0.4%19.7%

Competitors are the stored peer set for SPOK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(22.18M)21.86M15.67M14.97M15.88M
Depreciation & Amortization10.45M3.57M4.5M4.15M3.43M
Deferred Income Tax(5.48M)903K6.38M4.57M5.17M
Stock-Based Compensation7.24M3.83M4.06M4.96M5.01M
Change in Working Capital1.12M(3.63M)(5.37M)(566K)(966K)
Accounts Receivables1.83M(1.76M)2.58M506K(1.96M)
Inventory3.36M0000
Accounts Payables(679K)(2.26M)(5.22M)(1.18M)(1.74M)
Other Working Capital(3.39M)387K(2.73M)112K2.73M
Other Non-Cash Items16.83M(20.07M)950K846K430K
Operating Cash Flow7.97M6.46M26.18M28.92M28.95M
Capital Expenditures(15.24M)(3.78M)(3.42M)(3.21M)(3.75M)
Acquisitions (Net)10.84M(15.03M)000
Purchases of Investments(44.99M)(14.97M)000
Sales of Investments60M30M000
Other Investing Activities(10.84M)15.03M00701K
Investing Cash Flow(225K)11.26M(3.42M)(3.21M)(3.05M)
Debt Repayment00000
Common Stock Issued0000312K
Common Stock Repurchased(1.86M)(1.21M)(1.25M)(2.43M)(2.84M)
Dividends Paid(10.03M)(25.01M)(25.64M)(26.38M)(27.26M)
Other Financing Activities132K0210K272K0
Financing Cash Flow(11.75M)(26.22M)(26.68M)(28.54M)(29.79M)
Effect of Forex Changes(136K)(321K)145K(20K)28K
Net Change in Cash(4.15M)(8.83M)(3.77M)(2.84M)(3.87M)
Free Cash Flow(7.27M)2.68M22.77M25.71M25.2M

Spok Holdings, Inc.

NASDAQ:SPOK

Intrinsic Alpha fair value

Locked

Current Price

$10.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.